{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:32:02Z","timestamp":1766086322932},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1990,6,1]],"date-time":"1990-06-01T00:00:00Z","timestamp":644198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1990,6]]},"DOI":"10.1007\/bf02244140","type":"journal-article","created":{"date-parts":[[2005,11,14]],"date-time":"2005-11-14T23:35:09Z","timestamp":1132011309000},"page":"274-281","source":"Crossref","is-referenced-by-count":17,"title":["Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia"],"prefix":"10.1007","volume":"101","author":[{"given":"D. H.","family":"Wiles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. G.","family":"McCreadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02244140_CR1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00431773","volume":"87","author":"AC Altamura","year":"1985","unstructured":"Altamura AC, Curry SH, Montgomery S, Wiles DH (1985) Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients. Psychopharmacology 87:30\u201333","journal-title":"Psychopharmacology"},{"key":"BF02244140_CR2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1192\/bjp.124.5.420","volume":"124","author":"PJV Beumont","year":"1974","unstructured":"Beumont PJV, Corker CS, Friesen HG, Kolakowska T, Mandelbrote BM, Marshall J, Murray MAF, Wiles DH (1974) The effects of phenothiazines on endocrine function. II. Effects in men and post-menopausal women. Br J Psychiatry 124:420\u2013430","journal-title":"Br J Psychiatry"},{"key":"BF02244140_CR3","unstructured":"British National Formulary (1984) British Medical Association and the Pharmaceutical Society of Great Britain, London"},{"key":"BF02244140_CR4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1017\/S0033291700016160","volume":"8","author":"RJ Chalmers","year":"1978","unstructured":"Chalmers RJ, Bennie EH (1978) The effect of fluphenazine on basal prolactin concentrations. Psychol Med 8:483\u2013486","journal-title":"Psychol Med"},{"key":"BF02244140_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00431778","volume":"87","author":"SS Chang","year":"1985","unstructured":"Chang SS, Javaid JI, Dysken MW, Casper RC, Janicak PG, Davis JM (1985) Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia. Psychopharmacology 87:55\u201358","journal-title":"Psychopharmacology"},{"key":"BF02244140_CR6","first-page":"108","volume":"20","author":"G Chouinard","year":"1984","unstructured":"Chouinard G, Annable L, Campbell W, Boisvert D, Bradwejn J (1984) A double-blind controlled trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia. Psychopharmacol Bull 20:108\u2013109","journal-title":"Psychopharmacol Bull"},{"key":"BF02244140_CR7","first-page":"41","volume-title":"Depot antipsychotics in practice","author":"JC Cookson","year":"1986","unstructured":"Cookson JC, Kennedy NM, Gribbon D (1986) Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate. In: Silverstone T (ed) Depot antipsychotics in practice. Clinical Neuroscience Publishers, London, pp 41\u201351"},{"key":"BF02244140_CR8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-349-05929-4_7","volume-title":"Clinical pharmacology in psychiatry, neuroleptic and antidepressant research","author":"I Creese","year":"1981","unstructured":"Creese I, Lader S, Rosenberg B (1981) A radioreceptor assay for neuroleptic drugs. In: Usdin E, Dahl SG, Gram LF, Lingjaerde O (eds) Clinical pharmacology in psychiatry, neuroleptic and antidepressant research. Macmillan, London, pp 79\u2013104"},{"key":"BF02244140_CR9","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(78)91017-6","volume":"I","author":"SH Curry","year":"1978","unstructured":"Curry SH, Whelpton R, Deschepper PJ, Vrancks S, Schiff AA (1978) Plasma fluphenazine concentrations after injections of long-acting esters. Lancet I:1217\u20131218","journal-title":"Lancet"},{"key":"BF02244140_CR10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2125.1979.tb00941.x","volume":"7","author":"SH Curry","year":"1979","unstructured":"Curry SH, Whelpton R, Deschepper PJ, Vrancks S, Schiff AA (1979) Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man. Br J Clin Pharmacol 7:325\u2013331","journal-title":"Br J Clin Pharmacol"},{"key":"BF02244140_CR11","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archpsyc.1976.01770070088010","volume":"33","author":"JM Davis","year":"1976","unstructured":"Davis JM (1976) Comparative doses and costs of antipsychotic medication Arch Gen Psychiatry 33:858\u2013861","journal-title":"Arch Gen Psychiatry"},{"key":"BF02244140_CR12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1600-0447.1980.tb00621.x","volume":"62","author":"R Deberdt","year":"1980","unstructured":"Deberdt R, Elens P, Berghmans W, Heykants J, Woestenborghs R, Driesens F, Reyntjens A, Van Wijngaarden I (1980) Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. Acta Psychiatr Scand 62:356\u2013363","journal-title":"Acta Psychiatr Scand"},{"key":"BF02244140_CR13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1192\/bjp.148.5.560","volume":"148","author":"H Cuyper De","year":"1986","unstructured":"De Cuyper H, Ballen J, Van Praag HM, Verstraeten D (1986) Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration. Br J Psychiatry 148:560\u2013566","journal-title":"Br J Psychiatry"},{"key":"BF02244140_CR14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","volume":"26","author":"JP Feighner","year":"1972","unstructured":"Feighner JP, Robins E, Guze S, Woodruff RA, Winokur G, Munoz R (1972) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26:57\u201362","journal-title":"Arch Gen Psychiatry"},{"key":"BF02244140_CR15","first-page":"319","volume":"20","author":"A Forsman","year":"1976","unstructured":"Forsman A, \u00d6hman R (1976) Pharmacokinetic studies on haloperidol in man. Curr Ther Res 20:319\u2013336","journal-title":"Curr Ther Res"},{"key":"BF02244140_CR16","first-page":"653","volume":"16","author":"DJ Goode","year":"1981","unstructured":"Goode DJ, Meltzer HY, Fang VF (1981) Daytime variation in serum prolactin levels in patients receiving oral and depot antipsychotic medication. Biol Psychiatry 16:653\u2013662","journal-title":"Biol Psychiatry"},{"key":"BF02244140_CR17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/clpt.1983.65","volume":"33","author":"FO Holley","year":"1983","unstructured":"Holley FO, Magliozzi JR, Stanski DR, Lombrozo L, Hollister LE (1983) Clin Pharmacol Ther 33:477\u2013484","journal-title":"Clin Pharmacol Ther"},{"key":"BF02244140_CR18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-2007-1017373","volume":"18","author":"W Kissling","year":"1985","unstructured":"Kissling W, Moller HJ, Walter K, Wittman B, Krueger R, Trenk D (1985) Double blind comparison of haloperidol decanoate and fluphenazine decanoate. Effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention. Pharmacopsychiatry 18:240\u2013245","journal-title":"Pharmacopsychiatry"},{"key":"BF02244140_CR19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1192\/bjp.139.5.400","volume":"139","author":"T Kolakowska","year":"1981","unstructured":"Kolakowska T, Braddock L, Wiles D, Franklin M, Gelder M (1981) Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge. Br J Psychiatry 139:400\u2013412","journal-title":"Br J Psychiatry"},{"key":"BF02244140_CR20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/266639a0","volume":"266","author":"G Langer","year":"1977","unstructured":"Langer G, Sachar EJ, Gruen PH, Halpern FS (1977) Human prolactin responses to neuroleptic drugs correlate with antispychotic potency. Nature 266:639\u2013640","journal-title":"Nature"},{"key":"BF02244140_CR21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF00178510","volume":"88","author":"SR Marder","year":"1986","unstructured":"Marder SR, Hawes EM, Van Putten T, Hubbard JW, McKay G, Mintz J, May PRA, Midha KK (1986) Fluphenazine levels in patients receiving low and conventional dose of fluphenazine decanoate. Psychopharmacology 88:480\u2013483","journal-title":"Psychopharmacology"},{"key":"BF02244140_CR22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1192\/bjp.151.3.333","volume":"151","author":"JP McKane","year":"1987","unstructured":"McKane JP, Robinson ADT, Wiles DH, McCreadie RG, Stirling GS (1987) Haloperidol decanoate -v- fluphenazine decanoate as maintenance therapy in chronic psychiatric in-patients. Br J Psychiatry 151:333\u2013336","journal-title":"Br J Psychiatry"},{"key":"BF02244140_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000117751","volume":"6","author":"D Naber","year":"1980","unstructured":"Naber D, Finkbeiner C, Fischer B, Zander KJ, Ackenheil M (1980) Effects of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: relations to psychopathology and extra-pyramidal symptoms. Neuropsychobiology 6:181\u2013189","journal-title":"Neuropsychobiology"},{"key":"BF02244140_CR24","first-page":"115","volume-title":"Pharmacokinetics of psychoactive drugs: blood levels and clinical response","author":"H Nasrallah","year":"1979","unstructured":"Nasrallah H, Rivera-Calimlim L, Rogol AD, Gillin JE, Wyatt RJ (1979) Fluphenazine decanoate and prolactin: plasma concentrations and clinical response. In: Merlis S, Gottschalk L (eds) Pharmacokinetics of psychoactive drugs: blood levels and clinical response. SP Medical and Scientific Books, New York London, pp 115\u2013123"},{"key":"BF02244140_CR25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bmj.3.5826.561","volume":"3","author":"J Nokin","year":"1972","unstructured":"Nokin J, Vekemans M, L'Hermite M, Robyn C (1972) Circadian periodicity of serum prolactin concentration in man. Br Med J 3:561\u2013562","journal-title":"Br Med J"},{"key":"BF02244140_CR26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000468580","volume":"17","author":"AJM Reyntjens","year":"1982","unstructured":"Reyntjens AJM, Heykants JJP, Woestenborgs R, Gelders YG, Aerts TJL (1982) Pharmacokinetics of haloperidol decanoate. A two-year follow-up. Int Pharmacopsychiatry 17:238\u2013246","journal-title":"Int Pharmacopsychiatry"},{"key":"BF02244140_CR27","first-page":"586","volume":"32","author":"MS Richards","year":"1982","unstructured":"Richards MS, Dato ACA, Zalaschi NM, Balbo EA, Canero EC (1982) Monthly haloperidol substitutes for daily neuroleptics in psychotic in-patients. Curr Ther Res 32:586\u2013589","journal-title":"Curr Ther Res"},{"key":"BF02244140_CR28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0306-4530(80)90015-3","volume":"5","author":"RT Rubin","year":"1980","unstructured":"Rubin RT, Hays SE (1980) The prolactin secretory response to neuroleptic drugs: mechanisms, applications and limitations. Psychoneuroendocrinology 5:121\u2013137","journal-title":"Psychoneuroendocrinology"},{"key":"BF02244140_CR29","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.177.4055.1205","volume":"177","author":"JF Sassin","year":"1972","unstructured":"Sassin JF, Frantz AG, Weitzman ED, Kapen S (1972) Human prolactin: 24-hour pattern with increased release during sleep. Science 177:1205\u20131207","journal-title":"Science"},{"key":"BF02244140_CR30","first-page":"982","volume":"31","author":"E Suy","year":"1982","unstructured":"Suy E, Woestenborgs C, Heykants J (1982) Bioavailability and clinical effects of two different concentrations of haloperidol decanoate. Curr Ther Res 31:982\u2013991","journal-title":"Curr Ther Res"},{"key":"BF02244140_CR31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2125.1978.tb01636.x","volume":"5","author":"DH Wiles","year":"1978","unstructured":"Wiles DH, Franklin M (1978) Radioimmunoassay for fluphenazine in human plasma. Br J Clin Pharmacol 5:265\u2013268","journal-title":"Br J Clin Pharmacol"},{"key":"BF02244140_CR32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2125.1979.tb01045.x","volume":"8","author":"DH Wiles","year":"1979","unstructured":"Wiles DH, Gelder MG (1979) Plasma fluphenazine levels by radio-immunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate. Br J Clin Pharmacol 8:565\u2013570","journal-title":"Br J Clin Pharmacol"},{"key":"BF02244140_CR33","volume-title":"Clinical pharmacology in psychiatry, neuroleptic and anti-depressant research","author":"DH Wiles","year":"1981","unstructured":"Wiles DH, Stump K, Franklin M, Fraser S (1981) Preliminary assessment of a calf caudate radioreceptor assay for the estimation of neuroleptic drugs in plasma: comparison with other techniques. In: Usdin E, Dahl SG, Gram LF, Lingaerde O (eds) Clinical pharmacology in psychiatry, neuroleptic and anti-depressant research. Macmillan, London"},{"key":"BF02244140_CR34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-3956(77)90011-5","volume":"13","author":"RJ Wyatt","year":"1976","unstructured":"Wyatt RJ, Torgow JS (1976) A comparison of equivalent clinical potencies of neuroleptics as used to treat schizophrenia and affective disorders. J Psychiatr Res 13: 91\u201398","journal-title":"J Psychiatr Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02244140\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T19:31:57Z","timestamp":1557862317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02244140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,6]]}},"alternative-id":["BF02244140"],"URL":"https:\/\/doi.org\/10.1007\/bf02244140","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,6]]}}}